Randomized controlled trial demonstrates the benefit of RGTA(®) based matrix therapy to treat tendinopathies in racing horses

A randomized controlled trial was performed on racing horses, to evaluate the efficacy of a new class of therapeutic agents in regenerative medicine—ReGeneraTing Agents(®) (RGTA(®)), to treat tendinopathies. Preliminary uncontrolled studies on tendon healing in racing horses with RGTA(®) (OTR4131)—E...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacquet-Guibon, Sandrine, Dupays, Anne-Gaelle, Coudry, Virginie, Crevier-Denoix, Nathalie, Leroy, Sandrine, Siñeriz, Fernando, Chiappini, Franck, Barritault, Denis, Denoix, Jean-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844532/
https://www.ncbi.nlm.nih.gov/pubmed/29522564
http://dx.doi.org/10.1371/journal.pone.0191796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844532/
https://www.ncbi.nlm.nih.gov/pubmed/29522564
http://dx.doi.org/10.1371/journal.pone.0191796

Ejemplares similares